UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria

Antimicrobial Agents and Chemotherapy, 2008-01, Vol.52 (1), p.37-44

2008

Volltextzugriff (PDF)

A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5650-5654

2012

Volltextzugriff (PDF)

Commentary: "Emergency Use Authorization for Remdesivir: A Pediatric Perspective"

The Pediatric infectious disease journal, 2020-09, Vol.39 (9), p.e234-e234

2020

Volltextzugriff (PDF)

Children's medicines in Tanzania: a national survey of administration practices and preferences

PloS one, 2013-03, Vol.8 (3), p.e58303-e58303

2013

Volltextzugriff (PDF)

Pharmacometrics-Based Dose Selection of Levofloxacin as a Treatment for Postexposure Inhalational Anthrax in Children

Antimicrobial Agents and Chemotherapy, 2010-01, Vol.54 (1), p.375-379

2010

Volltextzugriff (PDF)

Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3294-3301

2009

Volltextzugriff (PDF)

Probability of Target Attainment for Ceftobiprole as Derived from a Population Pharmacokinetic Analysis of 150 Subjects

Antimicrobial Agents and Chemotherapy, 2007-07, Vol.51 (7), p.2378-2387

2007

Volltextzugriff (PDF)

Antibiotics needed to treat multidrug-resistant infections in neonates

Bulletin of the World Health Organization, 2022-12, Vol.100 (12), p.797-807

2022

Volltextzugriff (PDF)

Improving Drug Formulations for Neonates: Making a Big Difference in Our Smallest Patients

The Journal of pediatrics, 2012-11, Vol.161 (5), p.947-949.e1

2012

Volltextzugriff (PDF)

Ensuring continued progress for development of COVID-19 therapeutics in children

Pediatric research, 2021-12, Vol.90 (6), p.1112-1114

2021

Volltextzugriff (PDF)

Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative

Contemporary clinical trials communications, 2018-03, Vol.9 (C), p.7-12

2018

Volltextzugriff (PDF)

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

Clinical infectious diseases, 2008-03, Vol.46 (5), p.647-655

2008

Volltextzugriff (PDF)

Key clinical research priorities for the pediatric community during the COVID-19 pandemic

Pediatric research, 2021-03, Vol.89 (4), p.730-732

2021

Volltextzugriff (PDF)

A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation

International journal of antimicrobial agents, 2012-03, Vol.39 (3), p.240-246

2012

Volltextzugriff (PDF)

Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigators

Contemporary clinical trials communications, 2018-03, Vol.9 (C), p.115-120

2018

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis of Ceftobiprole for Treatment of Complicated Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.1228-1230

2009

Volltextzugriff (PDF)

Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin

Pediatrics (Evanston), 2014-07, Vol.134 (1), p.e146-e153

2014

Volltextzugriff (PDF)

Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach

Journal of the Pediatric Infectious Diseases Society, 2019-03, Vol.8 (1), p.60-62

2019

Volltextzugriff (PDF)

Pharmacodynamic Profiling of Ceftobiprole for Treatment of Complicated Skin and Skin Structure Infections

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3371-3374

2009

Volltextzugriff (PDF)

Measuring the Effects of Supratherapeutic Doses of Levofloxacin on Healthy Volunteers Using Four Methods of QT Correction and Periodic and Continuous ECG Recordings

Journal of clinical pharmacology, 2004-05, Vol.44 (5), p.464-473

2004

Volltextzugriff (PDF)

Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.1790-1797

2003

Volltextzugriff (PDF)

Inclusion of Adolescents in Adult Clinical Trials: Report of the Institute for Advanced Clinical Trials for Children’s Pediatric Innovation Research Forum

Therapeutic innovation & regulatory science, 2021-07, Vol.55 (4), p.773-778

2021

Volltextzugriff (PDF)

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team

Clinical infectious diseases, 2016-08, Vol.63 (suppl 2), p.S29-S36

2016

Volltextzugriff (PDF)

Characterization and Dynamics of Middle Ear Fluid and Nasopharyngeal Isolates of Streptococcus pneumoniae from 12 Children Treated with Levofloxacin

Antimicrobial Agents and Chemotherapy, 2008-01, Vol.52 (1), p.378-381

2008

Volltextzugriff (PDF)

Anti-MRSA β-lactams in development, with a focus on ceftobiprole: the first anti-MRSA β-lactam to demonstrate clinical efficacy

Expert opinion on investigational drugs, 2007-04, Vol.16 (4), p.419-429

2007

Volltextzugriff (PDF)

1 – 25 von 345

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(262)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria

A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections

Commentary: "Emergency Use Authorization for Remdesivir: A Pediatric Perspective"

Children's medicines in Tanzania: a national survey of administration practices and preferences

Pharmacometrics-Based Dose Selection of Levofloxacin as a Treatment for Postexposure Inhalational Anthrax in Children

Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole

Probability of Target Attainment for Ceftobiprole as Derived from a Population Pharmacokinetic Analysis of 150 Subjects

Antibiotics needed to treat multidrug-resistant infections in neonates

Improving Drug Formulations for Neonates: Making a Big Difference in Our Smallest Patients

Ensuring continued progress for development of COVID-19 therapeutics in children

Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

Key clinical research priorities for the pediatric community during the COVID-19 pandemic

A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation

Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigators

Population Pharmacokinetic Analysis of Ceftobiprole for Treatment of Complicated Skin and Skin Structure Infections

Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin

Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach

Pharmacodynamic Profiling of Ceftobiprole for Treatment of Complicated Skin and Skin Structure Infections

Measuring the Effects of Supratherapeutic Doses of Levofloxacin on Healthy Volunteers Using Four Methods of QT Correction and Periodic and Continuous ECG Recordings

Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States

Inclusion of Adolescents in Adult Clinical Trials: Report of the Institute for Advanced Clinical Trials for Children’s Pediatric Innovation Research Forum

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team

Characterization and Dynamics of Middle Ear Fluid and Nasopharyngeal Isolates of Streptococcus pneumoniae from 12 Children Treated with Levofloxacin

Anti-MRSA β-lactams in development, with a focus on ceftobiprole: the first anti-MRSA β-lactam to demonstrate clinical efficacy

Suchergebnisse filtern